Beschreibung
M.D. 1. Introduction. 9 2. Risk Factors for the Development of Azotemia in Acute Tumor Lysis Syndrome. 10 3. Metabolic Abnormalities That Occur during Acute Tumor Lysis Syndrome. 11. 4. Prevention of Acute Tumor Lysis Syndrome: Management prior to Beginning Chemotherapy. 13. 5. Posttreatment Management: Indications for Dialysis. 14. References. 15.
Herstellerkennzeichnung:
Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE
E-Mail: juergen.hartmann@springer.com




































































































